NSEChange in Management30 Jun 2026 · 30 Jun 2026, 06:37 pm

Change in Management

Morepen Laboratories Limited · MOREPENLAB

✦ AI SummaryMgmt Change

Morepen Laboratories Limited has informed the Exchange about the elevation and change in designation of Mr. Sanjay Suri from Whole-time Director to Managing Director with effect from 1st July 2026, for the balance tenure of his existing term, i.e., up-to 12th August 2028.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Morepen Laboratories Limited has informed the Exchange about elevation and change in designation of Mr. Sanjay Suri

Attachments (1)

📄

MOREPENLAB_30062026183730_Draft-SEIntimation30062026.pdf

pdf

Download →
View document text
Date: 30/06/2026 National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Mumbai- 400 051 Dalal Street, Mumbai- 400 001 Symbol: MOREPENLAB Scrip Code: 500288 Subject: Outcome of the meeting of the Board of Directors of the company Ref.: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Dear Sir/Madam, This is to inform you that, pursuant to the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the company, in their meeting held on Tuesday, 30th June 2026 (commenced at 05.00 p.m. and concluded at 6.15 p.m.), have, inter-alia, considered and approved the elevation and change in designation of Mr. Sanjay Suri (DIN: 00041590) from ‘Whole-time Director’ to ‘Managing Director’ with effect from 1st July 2026, for the balance tenure of his existing term, i.e., up-to 12th August 2028, subject to the approval of members of the company within the prescribed statutory timelines. Consequent upon his elevation and change in designation as the Managing Director of the Company, Mr. Sanjay Suri will jointly oversee the management and operations of the Company with Mr. Sushil Suri, Chairman & Managing Director, with clearly defined roles and responsibilities aligned to their respective areas of expertise. The details as required under the SEBI Listing Regulations read with SEBI master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026, is given in the Annexure. You are requested to take the same on record. Thanking you, Yours faithfully, For Morepen Laboratories Limited Vipul Kumar Srivastava Company Secretary F-12148 Encl.: a/a. Morepen Laboratories Limited CIN NO. L24231 HP1984PLC006028 Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA TEL.: +91 124 4892000, E-mail: corporate@morepen.com, Website: www.morepen.com Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: plants@morepen.com Annexure Disclosure in terms of Regulation 30 read with SEBI master Circular No. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated 30th January 2026 S. no. Particulars Details 1. Reason for change viz. Elevation and change in designation of Mr. Sanjay appointment, re-appointment, Suri (DIN: 00041590) from Whole-time Director resignation, removal, death or to the Managing Director. otherwise; 2. Date of appointment/re- Date of appointment: 1st July 2026 appointment/cessation (as applicable) & term of Term of appointment: Based on the appointment/re-appointment; recommendation of the Nomination and Remuneration Committee, the Board has approved the elevation and change in designation of Mr. Sanjay Suri from Whole-time Director to the Managing Director with effect from 1st July 2026, for the balance tenure of his existing term, i.e., up- to 12th August 2028, subject to the approval of members the company within the prescribed statutory timelines. 3. Brief profile (in case of Mr. Sanjay Suri is a Bachelor of Science (B.Sc.), appointment); having more than thirty years of experience in pharmaceuticals industry. He has varied experience in the field of international sales and marketing, joint ventures, statutory and regulatory approvals (including USFDA), strategic planning, manufacturing operations, including finance, accounts and banking. 4. Disclosure of relationships Mr. Sanjay Suri is a member of promoter group of between directors (in case of the company and brother of Mr. Sushil Suri, appointment of a director); Chairman and Managing Director & Promoter of the company. 5. Other information Mr. Sanjay Suri is not debarred from holding the office of the Managing Director by virtue of any order passed by the SEBI or any other such authority. Morepen Laboratories Limited CIN NO. L24231 HP1984PLC006028 Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA TEL.: +91 124 4892000, E-mail: corporate@morepen.com, Website: www.morepen.com Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: plants@morepen.com